July 16, 2026 · Form 4 insider transaction
Callahan Jennifer L. bought 19,800 shares of Cingulate Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
The option vests as follows: 25% on March 31, 2027 and the remaining shares in substantially equal monthly installments over the 36-month period following the initial vesting date.; Vested option only becomes exercisable if the Issuer's NDA for CTx-1301 is approved by the FDA during 2027.; If the Issuer's NDA for CTx-1301 is not approved by the FDA during 2027, the option, including any vested portion, shall terminate.